欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/1612/004
药品名称Targin 5 mg/2,5 mg Retardtabletten
活性成分
    • naloxone hydrochloride 2.73 mg
    • oxycodone hydrochloride 5.25 mg
剂型Prolonged-release tablet
上市许可持有人Mundipharma GmbH De-Saint-Exupéry-Straße 10 60549 Frankfurt am Main Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Estonia (EE)
    • Slovakia (SK)
      Targin 5/2,5 mg
    • Slovenia (SI)
    • Croatia (HR)
    • Denmark (DK)
      Targin
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Targin 5 mg/2,5 mg Retardtabletten
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Targin
    • Cyprus (CY)
      targin 5/2,5mg p.r. tabs
许可日期2009/04/23
最近更新日期2024/04/17
药物ATC编码
    • N02AA55 oxycodone and naloxone
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase